Jaguar Health, Inc. (JAGX)Healthcare | Biotechnology | San Francisco, United States | NasdaqCM
2.25 USD
-0.06
(-2.597%) ⇩
(July 13, 2026, 4 p.m.
EDT)
After hours: 2.15 -0.10 (-0.100%) ⇩ (July 13, 2026, 7:49 p.m. EDT) |
Hot Take ↕ | July 11, 2026, 5:16 a.m. EDT
The immediate outlook is severely compromised by a brutal multi-year price collapse. The stock has endured four consecutive years of negative annual returns, culminating in a catastrophic -100% cumulative loss over the last nine years. This trajectory is not merely a correction; it is the market's definitive verdict on the company's deteriorating reality, rendering any 'value' narrative dangerous. While recent price action shows a minor bounce off the lows, the massive gap between the current price and the 200-day average suggests deep, unresolved selling pressure. The statistical forecast models also point to further downside, albeit with very low confidence, which aligns with the fundamental risks rather than offering a contrarian signal. There is no safe entry here for a short-term trade given the structural damage to the equity. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.914891 |
| AutoETS | 1.286700 |
| AutoARIMA | 1.286703 |
| MSTL | 1.298119 |
Forecast horizon: 60 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 27% |
| H-stat | 1.69 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.000 |
| Excess Kurtosis | 0.48 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 154.722 |
| Market Cap | 10,928,725 |
| Forward P/E | -0.40 |
| Beta | -0.09 |
| Profit Margins | -115.40% |
| Website | https://jaguar.health |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.9723849 |
| Address1 | 200 Pine Street |
| Address2 | Suite 400 |
| All Time High | 87,566,066,000.0 |
| All Time Low | 2.12 |
| Ask | 2.9 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 45,430 |
| Average Daily Volume3 Month | 92,778 |
| Average Volume | 92,778 |
| Average Volume10Days | 45,430 |
| Beta | -0.094 |
| Bid | 1.64 |
| Bid Size | 2 |
| Book Value | -38.115 |
| City | San Francisco |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 2.25 |
| Current Ratio | 0.647 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 2.28 |
| Day Low | 2.23 |
| Display Name | Jaguar Health |
| Dividend Date | 1,559,865,600 |
| Earnings Call Timestamp End | 1,779,798,600 |
| Earnings Call Timestamp Start | 1,779,798,600 |
| Earnings Timestamp | 1,779,307,200 |
| Earnings Timestamp End | 1,786,651,200 |
| Earnings Timestamp Start | 1,786,651,200 |
| Ebitda | -23,598,000 |
| Ebitda Margins | -0.79807 |
| Enterprise To Ebitda | -1.538 |
| Enterprise To Revenue | 1.227 |
| Enterprise Value | 36,286,052 |
| Eps Forward | -5.68 |
| Eps Trailing Twelve Months | -695.5 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 3.2201 |
| Fifty Day Average Change | -0.9700999 |
| Fifty Day Average Change Percent | -0.30126393 |
| Fifty Two Week Change Percent | -97.238495 |
| Fifty Two Week High | 96.25 |
| Fifty Two Week High Change | -94.0 |
| Fifty Two Week High Change Percent | -0.97662336 |
| Fifty Two Week Low | 2.12 |
| Fifty Two Week Low Change | 0.13000011 |
| Fifty Two Week Low Change Percent | 0.06132081 |
| Fifty Two Week Range | 2.12 - 96.25 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,431,437,400,000 |
| Float Shares | 576,578 |
| Forward Eps | -5.68 |
| Forward P E | -0.39612678 |
| Free Cashflow | -2,085,375 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 47 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.85062 |
| Gross Profits | 25,152,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.00637 |
| Held Percent Institutions | 0.00151 |
| Implied Shares Outstanding | 4,857,211 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,777,507,200 |
| Last Split Factor | 1:35 |
| Long Business Summary | Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. It operates through two segments, Animal Health and Human Health. The company focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products. Its lead prescription drug is Mytesi, an anti-secretory antidiarrheal drug for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy; and Canalevia-CA1, a prescription drug product for chemotherapy-induced diarrhea in dogs. It is also developing Crofelemer, an anti-secretory antidiarrheal drug, which is in Phase III clinical trial for prophylaxis of diarrhea in adult cancer patients; Phase II clinical trials for rare/orphan disease indications, including short bowel syndrome with intestinal failure and microvillus inclusion disease; diarrhea-predominant irritable bowel syndrome; and for idiopathic/functional diarrhea. In addition, the company is developing Mytesi which is in Phase III clinical trial for cancer therapy-related diarrhea, as well as Phase II clinical trial for irritable bowel syndrome; and NP-300, a second-generation antidiarrheal drug that is in Phase I clinical trial for symptomatic relief and treatment of moderate-to-severe diarrhea. The company is headquartered in San Francisco, California. |
| Long Name | Jaguar Health, Inc. |
| Market | us_market |
| Market Cap | 10,928,725 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_12827020 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -50,126,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 11,220,157 |
| Number Of Analyst Opinions | 1 |
| Open | 2.25 |
| Operating Cashflow | -7,542,000 |
| Operating Margins | 0.50227 |
| Payout Ratio | 0.0 |
| Phone | 415 371 8300 |
| Post Market Change | -0.09990001 |
| Post Market Change Percent | -4.4400005 |
| Post Market Price | 2.1501 |
| Post Market Time | 1,783,986,566 |
| Previous Close | 2.31 |
| Price Hint | 4 |
| Price To Book | -0.059031874 |
| Price To Sales Trailing12 Months | 0.36960077 |
| Profit Margins | -1.15395 |
| Quick Ratio | 0.242 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.059999943 |
| Regular Market Change Percent | -2.5974002 |
| Regular Market Day High | 2.28 |
| Regular Market Day Low | 2.23 |
| Regular Market Day Range | 2.23 - 2.28 |
| Regular Market Open | 2.25 |
| Regular Market Previous Close | 2.31 |
| Regular Market Price | 2.25 |
| Regular Market Time | 1,783,972,800 |
| Regular Market Volume | 6,096 |
| Return On Assets | -0.35864 |
| Revenue Growth | 8.156 |
| Revenue Per Share | 154.722 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 4,857,211 |
| Shares Percent Shares Out | 0.0152 |
| Shares Short | 73,828 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 64,056 |
| Short Name | Jaguar Health, Inc. |
| Short Percent Of Float | 0.0152 |
| Short Ratio | 0.83 |
| Source Interval | 15 |
| State | CA |
| Symbol | JAGX |
| Target High Price | 262.50027 |
| Target Low Price | 262.50027 |
| Target Mean Price | 262.50027 |
| Target Median Price | 262.50027 |
| Total Cash | 7,278,000 |
| Total Cash Per Share | 12.067 |
| Total Debt | 34,311,000 |
| Total Revenue | 29,569,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -695.5 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 29.616325 |
| Two Hundred Day Average Change | -27.366325 |
| Two Hundred Day Average Change Percent | -0.9240284 |
| Type Disp | Equity |
| Volume | 6,096 |
| Website | https://jaguar.health |
| Zip | 94,104 |